Company · CIK 1685616
Vector Therapeutics, Inc.
| CIK | 1685616 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-05-15 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-214306 | 2016-10-28 | 2017-05-23 | 13 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2017-05-23 | 424B4Final prospectus | 333-214306 | 0001493152-17-005797 |
| 2017-05-23 | 424B4Final prospectus | 333-214306 | 0001493152-17-005795 |
| 2017-05-10 | EFFECTDeclared effective | 333-214306 | 9999999995-17-001237 |
| 2017-05-08 | S-1/AAmendment | 333-214306 | 0001493152-17-004863 |
| 2017-05-08 | S-1/AAmendment | 333-214306 | 0001493152-17-004825 |
| 2017-04-27 | S-1/AAmendment | 333-214306 | 0001493152-17-004470 |
| 2017-04-12 | S-1/AAmendment | 333-214306 | 0001493152-17-003793 |
| 2017-03-17 | S-1/AAmendment | 333-214306 | 0001493152-17-002530 |
| 2017-02-23 | S-1/AAmendment | 333-214306 | 0001493152-17-001861 |
| 2017-02-21 | S-1/AAmendment | 333-214306 | 0001493152-17-001800 |
| 2017-01-17 | S-1/AAmendment | 333-214306 | 0001493152-17-000544 |
| 2016-12-21 | S-1/AAmendment | 333-214306 | 0001493152-16-016097 |
| 2016-10-28 | S-1Registration filed | 333-214306 | 0001493152-16-014336 |